Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Machida

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Gynecologic Oncology|July 8, 2019
Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancerKoji Matsuo, Yongmei Huang, Oliver Zivanovic, et al.
American Journal of Clinical Oncology|August 2, 2017
Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical CancerHiroko Machida, Aida Moeini, Marcia A Ciccone, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 14, 2017
Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United StatesHiroko Machida, Sarah E Eckhardt, Antonio V Castaneda, et al.
Journal of Gynecologic Oncology|February 6, 2018
Trends in single women with malignancy of the uterine cervix in United StatesHiroko Machida, Erin A Blake, Sarah E Eckhardt, et al.
Journal of Gynecologic Oncology|December 15, 2021
Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective studyEiji Kondo, Kenta Yoshida, Tsutomu Tabata, et al.
Gynecologic Oncology|January 20, 2020
Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based studyKoji Matsuo, Hiroko Machida, Brendan H Grubbs, et al.
Gynecologic Oncology|March 26, 2019
Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint studyHiroko Machida, Koji Matsuo, Wataru Yamagami, et al.
Journal of Clinical Medicine|November 6, 2019
Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group StudyKoji Matsuo, Muneaki Shimada, Shinya Matsuzaki, et al.
Journal of Gynecologic Oncology|March 17, 2023
Trend and characteristics of minimally invasive surgery for patients with endometrial cancer in JapanHiroshi Yoshida, Hiroko Machida, Koji Matsuo, et al.
International Journal of Clinical Oncology|January 8, 2026
Real-world safety and efficacy of immune checkpoint inhibitors in Japanese patients with persistent, recurrent, or metastatic cervical cancer: a multicenter prospective and retrospective studyKazuhisa Kitami, Shiho Kuji, Natsuko Kamiya, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Gynecologic Oncology|July 8, 2019
Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancerKoji Matsuo, Yongmei Huang, Oliver Zivanovic, et al.
American Journal of Clinical Oncology|August 2, 2017
Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical CancerHiroko Machida, Aida Moeini, Marcia A Ciccone, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 14, 2017
Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United StatesHiroko Machida, Sarah E Eckhardt, Antonio V Castaneda, et al.
Journal of Gynecologic Oncology|February 6, 2018
Trends in single women with malignancy of the uterine cervix in United StatesHiroko Machida, Erin A Blake, Sarah E Eckhardt, et al.
Journal of Gynecologic Oncology|December 15, 2021
Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective studyEiji Kondo, Kenta Yoshida, Tsutomu Tabata, et al.
Gynecologic Oncology|January 20, 2020
Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based studyKoji Matsuo, Hiroko Machida, Brendan H Grubbs, et al.
Gynecologic Oncology|March 26, 2019
Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint studyHiroko Machida, Koji Matsuo, Wataru Yamagami, et al.
Journal of Clinical Medicine|November 6, 2019
Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group StudyKoji Matsuo, Muneaki Shimada, Shinya Matsuzaki, et al.
Journal of Gynecologic Oncology|March 17, 2023
Trend and characteristics of minimally invasive surgery for patients with endometrial cancer in JapanHiroshi Yoshida, Hiroko Machida, Koji Matsuo, et al.
International Journal of Clinical Oncology|January 8, 2026
Real-world safety and efficacy of immune checkpoint inhibitors in Japanese patients with persistent, recurrent, or metastatic cervical cancer: a multicenter prospective and retrospective studyKazuhisa Kitami, Shiho Kuji, Natsuko Kamiya, et al.
Pageof 12